Plasma Metabolomics and Lipidomics Reveal Perturbed Metabolites in Different Disease Stages of Chronic Obstructive Pulmonary Disease
Juntuo Zhou,1,* Qiuyu Li,2,* Chengyang Liu,3 Ruifang Pang,1 Yuxin Yin3 1Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Beijing 100083, People’s Republic of China; 2Department of Respiratory and Critical Care Medicine, Peking University Third H...
Main Authors: | Zhou J, Li Q, Liu C, Pang R, Yin Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-03-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/plasma-metabolomics-and-lipidomics-reveal-perturbed-metabolites-in-dif-peer-reviewed-article-COPD |
Similar Items
-
An Updated Overview of Metabolomic Profile Changes in Chronic Obstructive Pulmonary Disease
by: Nan Ran, et al.
Published: (2019-06-01) -
Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma
by: Sureerat Padthaisong, et al.
Published: (2021-08-01) -
A Systematic Review of Metabolomic and Lipidomic Candidates for Biomarkers in Radiation Injury
by: Elisabeth Vicente, et al.
Published: (2020-06-01) -
Multiplatform Metabolomics Reveals Novel Serum Metabolite Biomarkers in Diabetic Retinopathy Subjects
by: Qiuhui Xuan, et al.
Published: (2020-11-01) -
LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma
by: Xiang Liu, et al.
Published: (2020-05-01)